High expression of apoptosis protein (Api-5) in chemoresistant triple-negative breast cancers: an innovative target-Reference-Cited by-同舟云学术

High expression of apoptosis protein (Api-5) in chemoresistant triple-negative breast cancers: an innovative target

Published:2019-11-12 Issue:61 Volume:10 Page:6577-6588
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Bousquet Guilhem¹²³⁴,Feugeas Jean-Paul⁵,Gu Yuchen¹,Leboeuf Christophe¹²,Bouchtaoui Morad El²,Lu He²,Espié Marc⁶,Janin Anne¹²⁷,Benedetto Melanie Di¹²³

Affiliation:

1. Université Paris Diderot, Sorbonne Paris Cité, Laboratoire de Pathologie, UMR-S 1165, F-75010, Paris, France

2. INSERM, U942, F-75010, Paris, France

3. Université Paris 13, Sorbonne Paris Cite, F-93000, Villetaneuse, France

4. AP-HP, Hôpital Avicenne, Medical Oncology, F-93000, Bobigny, France

5. INSERM, U1137-Paris, F-75018, France

6. AP-HP, Hôpital Saint-Louis, Centre des Maladies du Sein, F-75010, Université Paris Diderot, Sorbonne Paris Cité, INSERM CNRS UMR7212, Paris, France

7. AP-HP, Hôpital Saint-Louis, Laboratoire de Pathologie, F-75010, Paris, France

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. PROM2 overexpression induces metastatic potential through epithelial‐to‐mesenchymal transition and ferroptosis resistance in human cancers;Clinical and Translational Medicine;2024-03

2. Apoptosis Inhibitor 5: A Multifaceted Regulator of Cell Fate;Biomolecules;2024-01-22

3. Facts and prospects of peptide in targeted therapy and immune regulation against triple-negative breast cancer;Frontiers in Immunology;2023-08-25

4. Immunogenic cell death inducer peptides: A new approach for cancer therapy, current status and future perspectives;Biomedicine & Pharmacotherapy;2023-05

5. Altered expression of anti-apoptotic protein Api5 affects breast tumorigenesis;BMC Cancer;2023-04-25